Robuta

https://www.benzinga.com/news/earnings/22/11/29858306/aerie-pharmaceuticalss-return-on-capital-employed-overview
return on capitalaerie pharmaceuticalsemployedoverview
https://www.benzinga.com/news/earnings/22/12/29976256/heskas-return-on-capital-employed-overview
return on capitalemployedoverview
https://www.benzinga.com/news/earnings/23/05/32510056/looking-into-cvent-holdings-return-on-capital-employed
return on capitallooking intocventholdingemployed
https://www.benzinga.com/news/earnings/22/12/29940117/dollar-general-earnings-perspective-return-on-invested-capital
dollar generalinvested capitalearningsperspectivereturn
https://www.benzinga.com/news/earnings/23/05/32396239/goodyear-tire-rubbers-return-on-capital-employed-insights
return on capitalgoodyear tirerubberemployedinsights
https://www.benzinga.com/news/earnings/22/06/27843048/spartannashs-return-on-invested-capital-overview
Pulled from Benzinga Pro data, SpartanNash (NASDAQ:SPTN) showed a loss in earnings since Q4, totaling $19.29 million. Sales, on the other hand, increased by...
invested capitalspartannashreturnoverview
https://www.benzinga.com/news/21/06/21430655/return-on-capital-employed-overview-eagle-pharmaceuticals
During Q1, Eagle Pharmaceuticals (NASDAQ:EGRX) brought in sales totaling $41.25 million. However, earnings decreased 138.53%, resulting in a loss of $3.77...
return on capitalemployedovervieweaglepharmaceuticals
https://www.benzinga.com/news/earnings/22/08/28668675/luminar-technologiess-return-on-capital-employed-insights
Benzinga Pro data, Luminar Technologies (NASDAQ:LAZR) reported Q2 sales of $9.93 million. Earnings fell to a loss of $95.24 million, resulting in a 7.82%...
return on capitalluminar technologiesemployedinsights
https://www.benzinga.com/news/earnings/23/07/33371262/looking-into-bank-of-hawaiis-return-on-capital-employed
bank of hawaiireturn on capitallooking intoemployed
https://www.benzinga.com/news/earnings/23/04/32085365/alliancebernstein-holdings-return-on-capital-employed-overview
return on capitalalliancebernsteinholdingemployedoverview
https://www.benzinga.com/news/earnings/21/07/22249370/return-on-capital-employed-overview-kinder-morgan
After pulling data from Benzinga Pro it seems like during Q2, Kinder Morgan (NYSE:KMI) brought in sales totaling $3.15 billion. However, earnings decreased...
return on capitalkinder morganemployedoverviewnyse
https://www.benzinga.com/news/earnings/22/05/27189454/green-brick-partnerss-return-on-capital-employed-overview
Pulled from Benzinga Pro data, Green Brick Partners (NASDAQ:GRBK) posted Q1 earnings of $64.20 million, an increase from Q4 of 4.3%. Sales dropped to $393.62...
return on capitalgreenbrickpartnersemployed
https://www.benzinga.com/news/earnings/22/05/27474115/cranes-return-on-capital-employed-overview
According to Benzinga Pro, during Q1, Crane (NYSE:CR) earned $105.00 million, a 45.63% increase from the preceding quarter. Crane also posted a total of...
return on capitalcraneemployedoverviewnyse
https://www.benzinga.com/news/earnings/22/07/27931773/nemaura-medicals-return-on-capital-employed-insights
Nemaura Medical (NASDAQ:NMRD) brought in sales totaling $320.28 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased...
return on capitalnemaura medicalemployedinsights
https://www.benzinga.com/news/earnings/23/03/31422259/lifecore-biomedical-inc-common-stocks-return-on-capital-employed-insights
return on capitalcommon stockbiomedicalincemployed
https://ycharts.com/companies/VKTX/return_on_invested_capital
In depth view into Viking Therapeutics Return on Invested Capital including historical data from 2015, charts and stats.
invested capitalvikingtherapeuticsreturnanalysis
https://www.benzinga.com/news/earnings/23/07/33324237/looking-into-manhattan-bridge-capitals-return-on-capital-employed
looking intomanhattan bridgecapitalreturnemployed
https://www.benzinga.com/news/earnings/22/09/28896954/wells-fargos-return-on-capital-employed-insights
Pulled from Benzinga Pro data, Wells Fargo (NYSE:WFC) posted Q2 earnings of $2.95 billion, an increase from Q1 of 22.36%. Sales dropped to $17.03 billion, a...
return on capitalwells fargoemployedinsights
https://www.benzinga.com/news/earnings/22/11/29502099/looking-into-first-solars-return-on-invested-capital
Benzinga Pro data, First Solar (NASDAQ:FSLR) reported Q3 sales of $628.93 million. Earnings fell to a loss of $49.17 million, resulting in a 188.11% decrease...
looking intofirst solarinvested capitalreturn